Overall and progression-free survival in metastatic basosquamous cancer: A case series - 14/05/14
Doi : 10.1016/j.jaad.2014.03.003
Gefei Alex Zhu, BS, Christina Danial, BA, Andy Liu, BS, Shufeng Li, MS, Anne Lynn Su Chang, MD ⁎ 
Department of Dermatology, Stanford University School of Medicine, Redwood City, California
∗Correspondence to: Anne Lynn Su Chang, MD, Assistant Professor of Dermatology, Department of Dermatology, Stanford University School of Medicine, 450 Broadway St, Redwood City, CA 94063
| Funding sources: This study was supported in part by the Stanford Center for Clinical Informatics (UL1 RR025744 from NIH/NCRR) for the development of REDCap, and the NCI Cancer Center Support Grant 5P30CA124435 and Stanford NIH/NCRR CTSA Award Number UL1 RR025744 for the development of the Stanford Cancer Center Research Database. |
|
| Disclosure: Dr Chang has been a clinical investigator for studies sponsored by Infinity, Genentech, and Novartis. Mr Zhu, Ms Danial, Mr Liu, and Ms Li declare no conflicts of interest. |
© 2014
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 70 - N° 6
P. 1145-1146 - juin 2014 Retour au numéro
Article précédent
- Plasmacytoid dendritic cell involvement in the host response against keratoacanthoma
- Ossama Abbas, Lama Hussein, Mazen Kurban, Abdul-Ghani Kibbi
- Alopecia areata occurring during anti-TNF therapy: A national multicenter prospective study
- Marie Tauber, Sébastien Buche, Pascal Reygagne, Jean-Marie Berthelot, François Aubin, Pierre-Dominique Ghislain, Jean-David Cohen, Pascal Coquerelle, Elisa Goujon, Denis Jullien, Hedia Brixi, Géraldine Jeudy, Xavier Guennoc, Antoine Martin, Emilie Brénaut, Emmanuel Hoppé, Antoine Bertolotti, Thomas Bardin, Emmanuel Delaporte, Matthieu Allez, Hervé Bachelez, Julien Seneschal, Manuelle Viguier, Groupe de Recherche sur le Psoriasis de la Société Française de, Dermatologie, the Club Rhumatismes et Inflammation (CRI) and the Groupe d’études thérapeutiques des affections inflammatoires du tube digestif (GETAID)
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?